About Repligen

About Repligen

We are a US-based, global developer and manufacturer of highly innovative bioprocessing tools and technologies. We provide advanced systems and solutions that enable efficiencies and help set new standards for the way biological drugs are manufactured. We are "inspiring advances in bioprocessing" as a trusted partner in our customers' production of therapeutics and vaccines that are improving human health worldwide.

Leadership

Press Releases

View All

Events & Presentations

View All (opens in new window)

Latest Financial Results

Latest Financials

Investor Contacts

Company Headquarters

Repligen Corporation
41 Seyon St.Building 1, Suite 100
Waltham, MA 02453

800.622.2259 (Toll-Free)
781.250.0111 (Phone)
781.250.0115 (Fax)

Investors Relations Team

Jacob Johnson
Vice President, Investor Relations

Steven Chehames, IRC
Director, Investor Relations

investors@repligen.com

Transfer Agent

Equiniti Trust Company
PO Box 500
Newark, NJ 07101
800.937.5449 (Toll-Free)

www.equinti.com
helpast@equinity.com